New Solid Cancer Study Results from University of Texas MD Anderson Cancer Center Described (Phase I Litespark-001 Study of Belzutifan for Advanced Solid Tumors: Extended 41-month Follow-up In the Clear Cell Renal Cell Carcinoma Cohort)

Media coverage

• Title	New Solid Cancer Study Results from University of Texas MD Anderson Cancer Center Described (Phase I Litespark-001 Study of Belzutifan for Advanced Solid Tumors: Extended 41-month Follow-up In the Clear Cell Renal Cell Carcinoma Cohort)
  Media name/outlet	Clinical Trials Daily
  Country/Territory	United States
  Date	01/22/24
  Persons	Elizabeth R. Plimack